Clinical Trials Browser

NETWORK × Androgen Antagonists × 30 days × Clear all

NCT06235697 2026-04-14

ASCENDE-SBRT

Phase 3 Recruiting

Prostatic Neoplasms

NCT03419234 2026-04-01

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Phase 2 Active not recruiting

223 enrolled 14 charts

Prostatic Neoplasms